Publications by authors named "R J van de Ven"

Background/objectives: Most studies on the interaction between the immune system and cancer focus on T-cells, whereas studies on tumor-infiltrating B-lymphocytes (TIL-Bs) are still underrepresented. The aim of this study was to assess the prognostic impact of TIL-Bs in early- and advanced-stage oral cavity squamous cell carcinoma (OCSCC).

Methods: In total, 222 OCSCCs were studied.

View Article and Find Full Text PDF

This article is part of the Dendritic Cell Guidelines article series, which provides a collection of state-of-the-art protocols for the preparation, phenotype analysis by flow cytometry, generation, fluorescence microscopy, and functional characterization of mouse and human dendritic cells (DC) from lymphoid organs, and various nonlymphoid tissues. Within this article, detailed protocols are presented that allow for the generation of single-cell suspensions from human nonlymphoid tissues including lung, skin, gingiva, intestine as well as from tumors and tumor-draining lymph nodes with a subsequent analysis of dendritic cells by flow cytometry. Further, prepared single-cell suspensions can be subjected to other applications including cellular enrichment procedures, RNA sequencing, functional assays, etc.

View Article and Find Full Text PDF

Cancer is caused by an accumulation of somatic mutations and copy number alterations (CNAs). Besides mutations, these copy number changes are key characteristics of cancer development. Nonetheless, some tumors show hardly any CNAs, a remarkable phenomenon in oncogenesis.

View Article and Find Full Text PDF
Article Synopsis
  • Tertiary Lymphoid Structures (TLS) are linked to better cancer patient survival and responses to immunotherapies, but their effectiveness can vary based on size, composition, and maturation.
  • A study on Non-Small Cell Lung Carcinoma (NSCLC) used a multiplex immunofluorescent panel to analyze tumor samples from 406 patients, focusing on specific immune cell types within TLS.
  • The analysis led to a TLS scoring system that identified key features predictive of patient outcomes, showing correlations with other cancer biomarkers but not with PD-L1 status.
View Article and Find Full Text PDF

Immune checkpoint inhibitors are approved for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) but the response rate is only 13-18%. For an effective antitumor immune response, trafficking of immune cells to the tumor microenvironment (TME) is essential. We aimed to better understand immune cell migration as well as the involved chemokines in HNSCC.

View Article and Find Full Text PDF